# Study to Evaluate Benefits & Safety of Endourage Formula C™ Oral Drops in People With Post-Acute COVID-19 Syndrome.

> **NCT04828668** · NA · COMPLETED · sponsor: **Endourage, LLC** · enrollment: 32 (actual)

## Conditions studied

- Covid 19

## Interventions

- **DIETARY_SUPPLEMENT:** Targeted Wellness Formula C™ Sublingual Drops - 1200mg - 30 mL (Formula C)

## Key facts

- **NCT ID:** NCT04828668
- **Lead sponsor:** Endourage, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-02
- **Primary completion:** 2022-01-31
- **Final completion:** 2022-02-14
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04828668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04828668, "Study to Evaluate Benefits & Safety of Endourage Formula C™ Oral Drops in People With Post-Acute COVID-19 Syndrome.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04828668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*